For example, the deletion of the lysocardiolipin acyltransferase ALCAT-1 ameliorated NAFLD by inhibiting cardiolipin remodeling and improving both mitochondrial respiration and oxidative stress [11]. The gene discussed is LCLAT1; the disease is metabolic dysfunction-associated steatotic liver disease.